Korea Otsuka Pharmaceutical Co., Ltd.

42 clinical trials · Sponsor

Record	Firm	Date
Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) (NCT06674291)	Korea Otsuka Pharmaceutical Co., Ltd.	2024-11-30
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. (NCT05048069)	Korea Otsuka Pharmaceutical Co., Ltd.	2021-10-07
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis (NCT04189705)	Korea Otsuka Pharmaceutical Co., Ltd.	2019-12-30
To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers (NCT04150146)	Korea Otsuka Pharmaceutical Co., Ltd.	2019-07-05
Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease (NCT03949894)	Korea Otsuka Pharmaceutical Co., Ltd.	2019-07-01
To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers (NCT04150172)	Korea Otsuka Pharmaceutical Co., Ltd.	2019-04-22
Iclusig PMS in CML or Ph+ALL Patients (NCT03709017)	Korea Otsuka Pharmaceutical Co., Ltd.	2018-08-07
A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression (NCT03423680)	Korea Otsuka Pharmaceutical Co., Ltd.	2018-02-22
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics (NCT03376763)	Korea Otsuka Pharmaceutical Co., Ltd.	2017-11-21

Every clearance here is in the API, with alerts when new ones post.